TGFB1 and neoplasm: Similarly, the utilization of small interfering RNA targeting TGF-β has shown promise in attenuating tumor metastasis in vivo, substantiating the prospect of impeding EMT initiation via the inhibition of TGF-β secretion within the tumor cell matrix.